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AND WOMEN IN THE 45-55-YEAR AGE GROUP
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MASTER OF SCIENCE IN WELLNESS COACHING AND DISEASE PREVENTION
MINNESOTA STATE UNIVERSITY, MANKATO
MANKATO, MINNESOTA
MAY 2020
ABSTRACT
Statement of the Problem: Adults, 50 years or older, should have a screening
colonoscopy every ten years and fecal immunochemical test (FIT) every year. However,
close to 22 million adults between the ages of 50-75 in the U.S. have never been
screened for colorectal cancer, which delays treatment and can be fatal if the cancer is
not found in time.
Procedure: This study used a descriptive, cross-sectional, survey-based design and a
convenience sample of men and women between 45 and 55 years old to assess
colorectal screening practices, barriers to screening, and knowledge levels about
colorectal cancer screening.
Findings: A total of 161 survey participants, mostly non-Hispanic Caucasian/white
females, met the eligibility criteria. Just over half have had a colonoscopy and some
before age 50 but sigmoidoscopies and use of home stool blood tests were few. The
greatest barriers were no doctor’s order and not being told to get screened and the
least were lack of provider and other types of colon exams. Almost half complained that
the prep was too painful, unpleasant, or embarrassing. Overall, the barriers were
perceived as greater for women than for men. More participants knew about what
starting age CRCS is recommended for but there was a significant knowledge deficit
related to how often screening should occur, which presents an important opportunity
for education.
Conclusions and Recommendations: Colorectal cancer should not be treated any
differently than prostate or breast cancer and more public health campaigns are needed
to assure patients that screening equals prevention. Automatic reminders to EMRs can
serve both, the patient, and the provider. Adding health coaches to the healthcare team
permanently will empower patients to take responsibility in their own healthcare and
can positively impact health behavior change, including screening adherence.
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Chapter I
Introduction
Colorectal cancer (CRC) is projected to claim over 50,000 lives in the United
States in 2019 and more than 145,000 new colon and rectal cancer diagnoses are
anticipated (American Cancer Society [ACS], 2019). The risk for developing colorectal
cancer in a person’s lifetime is “about 1 in 22 (4.49%) for men and 1 in 24 (4.15%) for
women” (ACS, 2019, para. 2). However, timely compliance with screening
recommendations can prevent most colorectal cancer occurrence and over half of
colorectal cancer deaths (Cossu, Saba, Minerba, & Mascalchi, 2018).
DiPietro, DeLoia, and Barbiero (2019) related that cancer happens because of
uninhibited cell growth and, in the case of colorectal cancer, those cells typically form in
the inner lining of the colon or rectum. The authors likewise stated that cancer typically
originates in neoplastic polyps, which can be benign, precancerous, or malignant. Since
colon and rectal cancers are so closely related in their location, appearance, and
presentation, they are often referred to collectively as colorectal cancer, but they can be
separated for research and treatment purposes (Van der Sijp et al., 2016). Rectal tumors
can be found in the rectum, which extends about six inches from the anal opening and
grow to extend past the rectal wall to surrounding organs (Paschke et al., 2018).
Paschke et al. (2018) expand by proposing that, even though the colon and rectum are
connected as part of the large bowel, colon cancer and rectal cancer should be
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separated as two different diseases because of location within the body, potential
complications, rate at which a cure is possible, and difference in surgical approaches.
Colorectal cancer screening (CRCS) can be accomplished by structural exams or
via stool-based tests (Issa & Noureddine, 2017). As noted by the ACS (2019), CRCS tools
include direct visualization of the length of the colon wall via colonoscope during a
colonoscopy. A shorter version of the colonoscopy, the flexible sigmoidoscopy, only
provides visualization of the lower third of the colon. The shorter version is not done as
frequently because much of the colon is skipped, which means that polyps and possible
cancer can be missed. The ACS (2019) furthermore mentioned that a virtual
colonoscopy via computed tomography (CT) scan can be done but it requires a full
bowel prep, there is radiation exposure, and if polyps are found, they cannot be
removed during this procedure and the patient must undergo colonoscopy after all.
Lastly, there are three different types of at-home stool sampling methods that all have
the potential to miss polyps and if positive, must be followed up with a colonoscopy
(ACS, 2019).
Statement of the Problem
The recommendations for CRCS are that patients at 50 years of age start having a
screening colonoscopy every ten years and fecal immunochemical test (FIT) every year
(Rex et al., 2017). The ACS (2019) recommends screening at age 45 for people who are
of average risk. Changes to those recommendations by the ACS are based on personal or
family history of colon polyps and/or colon cancer, personal history of inflammatory
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bowel disease, and the findings of above-mentioned tests. ACS recommendations also
state that a positive fecal immunochemical test triggers a follow-up colonoscopy and
that certain types of polyps, when found during colonoscopy or flexible sigmoidoscopy,
indicate the need for a three-year follow-up colonoscopy, rather than ten (ACS, 2019).
Colonoscopies are, therefore, not just preventative but also diagnostic procedures.
However, in the United States, “21.7 million adults aged 50 to 75 years […] have never
been screened for CRC [colorectal cancer]” (Centers for Disease Control and Prevention
[CDC], 2019, para. 2), which delays treatment and can be fatal if the cancer is not found
in time.
Factors Contributing to the Problem
Cossu, Saba, Minerba, and Mascalchi (2018) conveyed several elements
contributing to the delay of CRCS, including family, cultural, and socioeconomic
background; being male; not being able to get an appointment in a timely manner;
mental health concerns; level of education; and being obese. Additionally, the authors
pointed out that a knowledge deficit regarding the process of screening could create
fear of and anxiety over what the results may be or if there is any pain, and
embarrassment and helplessness could lead to low screening participation. HoneinAbouHaidar et al. (2016) similarly reported little awareness, understanding, and
knowledge of colorectal cancer and the purpose of CRCS; fear of cancer, screening
results, and possible outcomes related to a cancer diagnosis; poor attitudes and shame
toward CRCS; questionable efficacy of CRCS; no sense of urgency to get screened
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because of life responsibilities, scheduling conflicts, transportation issues, being unable
to find a person to accompany the patient, and a perception that other cancers might be
more important to screen for; insufficient health literacy; language barriers; and a
threat to masculinity among men as barriers to receive CRCS. Hasan et al. (2017) added
questionable safety, high cost, and low education levels to a list akin to the two
mentioned above. However, other reasons for delaying CRCS may exist and need to be
explored.
Significance of the Problem
Colorectal cancer is the third most frequently diagnosed cancer in men and
women in the U.S. and the second leading cause of cancer death in men and women
combined (ACS, 2019). Cossu et al. (2018) noted that, although there is a downward
trend, colorectal cancer is still one of the most prevalent reasons for cancer death and
illness globally. This type of cancer is preventable with timely screening at regular
intervals and chances for treatment and survival increase if the cancer is found and
diagnosed early (Wang et al., 2012). Nevertheless, about one third of adults aged 50 to
75 are not up to date with screening and more than 25% have never had a colonoscopy
screening (CDC, 2016). Overall survival and health-related quality of life in colorectal
cancer patients are influenced by race, marital status, level of education, age, income,
and alcohol use (Reyes et al., 2017). Insurance and socioeconomic status as well as the
number of comorbidities an individual has been diagnosed with have some bearing on
survival (Tannenbaum, Hernandez, Zheng, Sussman, & Lee, 2014). Additionally, survival
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is greatly dependent on what stage the cancer was diagnosed at and if it has
metastasized (Haggar & Boushey, 2009). Colorectal cancer related mortality is also
influenced by the location of the primary tumor because cancer in the right colon is less
prevalent but has worse outcomes (Peeters et al., 2018).
The age at which people get diagnosed with colon cancer is dropping and the
prevalence of colorectal cancer in adults under 40 years of age is growing (Campos,
2017). Imperiale, Kahi, and Rex (2018) pointed out a 22% rise in colorectal cancer
diagnoses in individuals less than 50 years of age in the years between 2000 and 2013.
Therefore, the recommended screening age was lowered to age 45 in 2018. However, if
more than a quarter of screening-eligible adults are not having their colonoscopies, then
the number of missed colon cancer cases and, ultimately death, also increases (CDC,
2016). The U.S. government set goals to reach 70.5% of adults to receive colorectal
cancer screening as part of the Healthy People 2020 initiative, which is a science-based
10-year agenda for the betterment of the health of all Americans (Department of Health
and Human Services [DHHS], 2019).
Purpose of the Study
The purpose of this study is to assess the extent to which participants received
their primary CRCS by the recommended age and barriers that prevented timely CRCS.
Furthermore, this study will evaluate the difference in barriers for timely initial CRSC for
men compared to women. The information obtained from this study is of critical
importance for public health campaigns to increase the number of people who have
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timely initial CRCS. It will also be useful for healthcare providers to help remove the
barriers for individuals to receive screening.
Research Questions
1. What are the colorectal cancer screening practices among males and females,
aged 45-55?
2. What potential barriers exist that prevent individuals from undergoing timely
colorectal cancer screening?
3. What are the knowledge levels of colorectal cancer screening among those who
have and have not received screening?
Limitations
1. The time (three weeks on social media and two weeks of GI clinic distribution) in
which the study was conducted limited responses.
2. The geographical area of distribution was limited due to the size of the study.
3. The study only focused on a limited age group.
4. Males as well as ethnic and racial groups were underrepresented.
5. Socioeconomic status and education level was not addressed.
6. Reasons for early CRCS were not included.
7. Other CRCS methods were left out.
Delimitations
1. The study was limited to men and women between the ages of 45 and 55 years
old, which is the recommended age at which to start CRCS.
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2. Data collection was limited to a portion of the spring semester 2020.
3. Participants were limited to those who can read and understand English.
Assumptions
1. Participants can understand the survey questions and follow the directions
provided to them.
2. Participants are honest in answering the survey questions.
Definitions
•

Adenoma: a benign tumor that originates in the epithelial tissue of a gland or
gland-like structure (National Cancer Institute [NCI], n.d.)

•

Benign: non-cancerous (NCI, n.d.)

•

Bowel prep: elimination of all solid matter from the intestines by elimination of
solid food intake for the duration of the prep and use of laxative medications
(American Gastroenterological Association [AGA], 2020)

•

Colonoscopy: visual inspection of the inside lining of the colon from cecum to
anus by use of colonoscope, a flexible tube with a light, camera, and hole to
insert instruments for polyp removal at the tip (NCI, n.d.)

•

Colorectal cancer screening: is used to try to find cancer before any signs or
symptoms appear but is referring to colonoscopies for the purpose of conducting
this study (American Society of Clinical Oncology [ASCO], 2019)

•

Epithelial tissue: the thin lining of all body surfaces, hollow organs, and body
cavities and the major tissue found in glands (NCI, n.d.)
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•

Flexible sigmoidoscopy: visual inspection of the inside lining of the last third of
the colon by use of colonoscope (ACSO, 2019)

•

Home stool blood test: a test that detects hidden blood in the stool which could
be an indicator for some type of bleeding in the digestive tract and warrants
further investigation if results are positive (ACSO, 2019)

•

Malignant: cancerous with the potential to extend and invade other areas of the
body (NCI, n.d.)

•

Neoplastic: a new and abnormal formation of tissue, may be cancerous or noncancerous (NCI, n.d.)

•

Polyp: a flat, or finger-like projection on the inside lining of the colon wall (NCI,
n.d.)

•

Polypectomy: the surgical removal of a polyp (NCI, n.d.)

•

Precancerous: a growth that is not yet but likely will become cancerous (NCI,
n.d.)
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Chapter 2
Review of Literature
Introduction
The purpose of this study was to assess the extent to which participants received
their primary CRCS by the recommended age and barriers that prevented timely CRCS.
Furthermore, this study evaluated the difference in barriers for timely initial CRSC for
men compared to women. This chapter provides relevant literature concerning
colorectal cancer epidemiology, risk factors, screening practices, barriers to screening,
and the importance of screening and prevention.
Colorectal Cancer Biology and Epidemiology
Colorectal cancer develops gradually. It begins with a growth, typically referred
to as a polyp, and can, in time, become cancerous (Ünal & Ozturk, 2015). Ahmed,
Johnson, Ahmed, and Iqbal (2014) stated that all colorectal cancers originate from small
polyps. Winawer et al. (1997) added that cancer typically does not develop in the
absence of adenomas. Growth patterns apart from adenomatous polyps are called
serrated polyps and occur less often but present similar risk for cancer development,
although only a fraction of all colorectal polyps will change into colorectal cancer (Øines,
Helsingen, Bretthauer, & Emilsson, 2017). Winawer et al. (1997) described the
progression from adenomatous polyps to colorectal cancer as slow and happening over
the span of many years. Once cancer has developed, it is categorized by the extent of
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growth from the original site in the inside lining of the colon wall to the outside lining,
nearby lymph nodes, and other structures or organs in the body (Winawer et al., 1997).
Colorectal cancer was found to be one of the primary reasons for cancer-related
illness and death (Kolligs, 2016) and the third most frequently diagnosed as well as the
third deadliest cancer in the United States (Kolligs, 2016). Marley and Nan (2016)
reported that approximately 135,430 new cases were diagnosed in 2017 and
approximately 50,260 deaths occurred in the same year. Brenner, Kloor, and Pox (2014)
observed similar statistics on a global scale, describing colorectal cancer as the fourth
most common oncological cause of death. Aran, Victorino, Thuler, and Ferreira (2016)
suggested there are an estimated 753,000 worldwide colorectal cancer deaths per year
and about 814,000 new cases for men and 664,000 for women in 2015. Favoriti et al.
(2016) remarked that mortality rates were significantly different by gender as well as by
race, with the latter likely due to socioeconomic diversity. The incidence rates account
for 9.7% of all cancer incidents worldwide (Aran, Victorino, Thuler, & Ferreira, 2016).
The above-mentioned findings substantiate that colorectal cancer constitutes
the third deadliest cancer in men and women, only following prostate and lung cancer
and breast and lung cancer in the United States respectively. However, even though
estimations accounted for 1,177,556 of U.S. residents to have lived with a colorectal
cancer diagnosis in 2013, those numbers were noted to be dwindling (Marley & Nan,
2016). Rawla, Sunkara, and Barsouk (2019) said that incidence and death rates in
persons over 50 years of age were decreasing in the United States and that death rates

11

have fallen significantly from 1975 to 2015. A study by Siegel et al. (2017) revealed
similar results, where the authors elaborated on the difference being due to an increase
in general acceptance of colorectal cancer screening. Siegel et al. (2017) also noticed a
change where “receipt of a colonoscopy in the past 10 years increased from 14% in 2000
to 41% in 2013 among individuals ages 50 to 54 years, from 16% to 52% in those ages 55
to 59 years, and from 25% to 63% in those ages 65 years and older” (p. 189). Other
reasons for a fall in incidence and mortality rates were said to be declining use of
tobacco products, especially cigarettes, and high consumption of red and processed
meat, as well as increasing use of aspirin (Siegel et al., 2017). Brenner, et al. (2014)
attributed the change in direction to the fact that more individuals had polyps removed
during sigmoidoscopy and colonoscopy.
Another noteworthy characteristic of colorectal cancer is to consider that the
age at first diagnosis is dropping (Rawla, Sunkara, & Barsouk, 2019). Aran et al. (2016)
predicted that there will be a rise in new colorectal cancer diagnoses in the 20-49-year
age group by 2030. Additionally, it was noted that there seems to be a disparity in
incidence rates by geographical location, with the higher numbers in more developed
area as well as in certain ethnicities. Over half of the global incidence of colorectal
cancer was prevalent in developed countries (Kolligs, 2016). Favoriti et al. (2016)
credited the reasoning behind that to varying exposures of diet and environment to
those who are genetically more susceptible, while Siegel et al. (2017) attributed lifestyle
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changes, such as unhealthy dietary patterns, overweight and obesity, and being
physically inactive, to the finding.
The five-year survival rate of colorectal cancer has been noted to be near 66% in
high-income countries around the world, while lower-income countries have survival
rates that are more than 16% lower (Brenner, Kloor, & Pox, 2014). Race, ethnicity, age,
and progression of disease at time of diagnosis all play a role in survival, because
colorectal cancer is detected in a timelier fashion and the treatment for it has been
more developed (Favoriti et al., 2016). Furthermore, mortality reduction was due to
advance in treatment, variations in risk factors, and increasing participation in screening
procedures (Siegel et al., 2017).
Colorectal Cancer Staging
The staging of colorectal cancer encompasses how deep into the colon wall the
cancer has grown (T stage), whether there is lymph node involvement (N stage), and any
metastases (M stage) (Park, Kim, Lee, Lee, & Han, 2017). Appropriate treatment of
colorectal cancer is determined by the staging of the disease through use of radiologic
imaging like computed tomography (CT) scans, magnetic resonance imaging (MRI),
transrectal ultrasound, or positron emission tomography (PET) scans (Lee & Lee, 2016).
Vega, Valentín, and Cubiella (2015) suggested that whether the outcome is positive or
negative as treatment is started is also dependent on the stage of the tumor. Correct
staging of colorectal cancer is, therefore, crucial for correct and appropriate treatment.
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Risk Factors for Colorectal Cancer
Colorectal cancer does not have one single specific cause but rather, there are
multiple elements involved in the development of the disease (Aran et al, 2016). Among
the most commonly named risk factors for colorectal cancer, which can accumulate
during the lifespan of any individual, are environmental influences, specifically
sedentary lifestyle, overweight and obesity, smoking, excessive alcohol use, and a diet
rich in processed meat and cholesterol and lacking fiber, folic acid, and vitamin B6, as
well as low socioeconomic status and living in countries with limited healthcare
resources (López, Albero, & Rodríguez-Montes, 2014). Winawer et al. (1997) cited
having one or more relative with a history of colorectal cancer as one element that
could increase the risk of also getting the disease. Kolligs (2016) estimated that 30%50% of the risk for colorectal cancer development can be associated with certain
lifestyle factors. However, it was noted by Brenner et al. (2014) that no one of the risk
factors is solely responsible for the majority of colorectal cancer diagnoses.
There are modifiable and non-modifiable risk factors that can contribute to the
development of colorectal cancer (Rawla, Sunkara, & Barsouk, 2019). Non-modifiable
factors, such as age, gender, race, personal health history of inflammatory bowel
disease, and heredity, are nothing any individual can change. Modifiable risk factors,
however, are the behavioral and lifestyle factors which can be adjusted to reduce the
risk of developing colon cancer and increase the chance of survival (Lee, Keum, &
Giovannucci, 2016).
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Risk increases with age and gender influences the probability of diagnosis. Kolligs
(2016) indicated that more than half of initial cancer diagnoses are made after age 70
and that men develop advanced cancer at twice the rate as and sooner in their lives
than women while Favoriti et al. (2016) proposed that colorectal cancer prevalence
increases considerably between the ages of 40 - 50 and in each 10-year period
thereafter. Although age increases the risk of colorectal cancer, more individuals under
45 years of age are receiving a colorectal cancer diagnosis and the incidence in this age
group grew by 22% between the years 2000 and 2013 (Weinberg, Marshall, & Salem,
2017). Kolligs (2016) pointed out that being male and having a close family member with
colorectal cancer carries the same risk whereas Aran et al. (2016) suggested that the
incidence in men is close to double than that in women.
In a study that was reviewed by Connell, Mota, Braghiroli, and Hoff (2017), it was
found that race or ethnicity influenced colorectal cancer incidence and that those who
are white had lower rates than those who are black. Favoriti et al. (2016) suggested
higher screening practices in those who are white because of differences in
socioeconomic status. Correspondingly, biological differences include higher genetic
predisposition at a younger age in those who are black and cancer occurrence mostly in
the right and proximal transverse colon (Favoriti et al., 2016). This is significant to
consider because cancers in that region of the colon are typically bigger in size (Baran et
al., 2018). Siegel et al. (2017) claimed that the highest incidence and mortality rates

15

were in non-Hispanic blacks and noted that the lowest rates could be found in Asian
Americans/Pacific Islanders.
Individuals with inflammatory bowel diseases, such as Crohn’s disease or
ulcerative colitis are also at increased risk for colorectal cancer due to chronic
inflammation of the bowel (Barsouk, Rawla, Barsouk, & Thandra, 2019). Relatedly,
Marley and Nan (2016) revealed that there is a correlation between inflammation
associated with an ulcerative colitis diagnosis and time spent in active flare-ups and the
development of colorectal cancer. In the same article, it was also noted that Crohn’s
disease, although also an inflammatory condition, increases the risk but at a lower rate
than ulcerative colitis. This was corroborated by Aran et al. (2016), who added that
colorectal cancer develops via numerous interactive molecular pathways, which makes
this type of cancer multifaceted and difficult to manage. Lastly, celiac disease, which is
an auto-immune disorder that reacts with inflammation to the exposure of gluten in the
gastrointestinal tract, can also increase the risk for development of colorectal cancer
(Barsouk et al., 2019).
A family history of colon cancer or even colon polyps represents another notable
risk factor and makes up about one third of the risk, which increases as the number of
biological relatives with a history increases and with the degree of the relative (Kolligs,
2016). That means that a mother’s or father’s history or diagnosis increases the risk far
more than an uncle’s or a cousin’s. Another crucial aspect to consider here is how old
the relative was when he or she was first diagnosed because the risk for colon cancer
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increased if the first-degree family member received their diagnosis at less than 50
years of age (Connell, Mota, Braghiroli, & Hoff, 2017). This will guide the age of first
screening for the individual in question. Brenner et al. (2014) noted that genetic
syndromes can also pose a risk but only make up less than 5% of colorectal cancer
incidences and related details to that effect remain unclear.
A correlation exists between the increased risk of developing colorectal cancer
and a Westernized lifestyle, which entails certain dietary habits, diabetes, excessive
alcohol and tobacco use, lack of weight management, and physical inactivity (Connell et
al., 2017). The dietary habits include eating a high-fat, meat-based diet, insufficient
amounts of dietary fiber intake from fruits, vegetables, and legumes (Turner & Lloyd,
2017). In a study conducted by Young et al. (2019), the authors concluded that lifestyle
factors alone as well as combined with inherited genetics increased colorectal cancer
risk, and that genetics alone carried an equal amount of risk as lifestyle.
Findings about how dietary practices increase the risk of colorectal cancer
development vary between studies. Particular attention is paid to red and processed
meat consumption (Turner & Lloyd, 2017). Santarelli, Pierre, and Corpet (2008) pointed
out that consuming processed meat might be more detrimental than the consumption
of red meat. Wilkins, McMechan, and Talukder (2018) noted that, although high fat
consumption has also been found to increase the risk, there was not enough evidence in
previous studies that adherence to a low-fat diet was cancer protective. Siegel et al.
(2017) suggested that folic acid may have a contradictory influence on colorectal cancer
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development in that it can be preventative of new growths, but also stimulate further
advance of existing ones. Øines, Helsingen, Bretthauer, and Emilsson (2017) found a
correlation between the presence of adenomas and unfavorable cholesterol levels at
the time of the screening.
Like dietary habits, body mass index (BMI) is a factor and important to consider.
Øines et al. (2017) wrote that there is a small link between BMI and development of
colorectal cancer. The authors noted that extra weight, as in overweight and obesity,
can cause persistent low-grade inflammation, which can compound the risk for colon
cancer. Behaviors consistent with a high-fat and high-meat diet, coupled with sedentary
lifestyle, result in rising numbers of overweight and obesity and influence cardiac health,
blood sugar levels, metabolism, hormone balance, and immune system function (Young
et al., 2019).
Numerous studies connect an increased risk for cancer development with
smoking habits. Aran et al. (2016) described tobacco smoke as containing over 7000
chemicals, including known carcinogens. They also related colorectal cancer incidence
and decreased survival with smoking. Øines et al. (2017) named smoking the number
one modifiable risk factor for the development of polyps and colorectal cancer due to
carcinogens which can cause permanent cigarette-specific genetic mutations inside of
the colon. Cigarette smoke also causes inflammation (Young et al., 2019), which was
mentioned earlier as one of the relatable causes for increase in risk. Bailie, Laughrey,
and Coleman (2017) alluded to molecular mutations in smokers that constitute a 2.5 to
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3.4-fold amplified risk for serrated or adenomatous polyps respectively. Hoffmeister,
Jansen, Stock, Chang-Claude, and Brenner (2014) described the risk for colorectal cancer
as being overcome by regular CRCS and polypectomy in those who were former
smokers, but for those that continue to smoke into older age, the risk increases.
Not unlike the increased risk presented by smoking, excessive alcohol
consumption can escalate the danger for colorectal cancer development. Walter et al.
(2016) cited the potentially fatal carcinogenic outcomes of alcohol metabolites and
alcohol-related nutritional deficiencies and malabsorption. Wang, Duan, Yang, and Lin
(2015) found that the more alcohol an individual consumes, the higher the risk for
development of colorectal cancer becomes. Furthermore, the authors pointed out that
alcohol consumption influences cancer death in general. Alcohol is also said to pose an
enhanced risk in individuals with a first-line relative with a history of colorectal cancer
(Rossi, Jahanzaib Anwar, Usman, Keshavarzian, & Bishehsari, 2018).
Physical activity is a critical factor for the prevention of colorectal cancer,
however not often mentioned separately in the literature. Rather, it is included in the
list of risk factors and lifestyle behaviors such as diet and smoking but elaborated on
more with prevention in mind. However, Santos Silva et al. (2018) reviewed a global
longitudinal study and found a correlation between physical inactivity and disabilityadjusted life-years related to colorectal cancer in Brazil.
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Colorectal Cancer Screening Practices
Colorectal cancer screening practices vary according to recommendations from
assorted organizations like the American Academy of Family Physicians, the American
Cancer Society, and U.S. Preventive Services Task Force but all have the following in
common: for those of average risk, screening via colonoscopy should begin at 50 and
end at 75 years of age unless risk factors, symptoms, personal or family history, or
previous screening results determine otherwise and repeated every ten years while
stool-based tests and flexible sigmoidoscopy are advised to be done more often
(Wilkins, McMechan, & Talukder, 2018). In addition, Wilkins et al. (2018) documented
that the recommended screening age decreases to 45 in African Americans per the
American College of Gastroenterology and the U.S. Multi-Society Task Force on
Colorectal Cancer, which was substantiated by Short, Layton, Teer, and Domagalsky
(2015), who added that screening in African Americans should begin at age 45 since the
colorectal cancer incidence in this population increases earlier. Colorectal cancer is a
slow-growing cancer which can be prevented by regular screening and straightforward
treatment if found early (Sorra, 2006). Screening and early intervention can, therefore,
decrease mortality and cost. According to Short et al. (2015), 50-75 years of age is when
routine screening should be performed on an individual of average risk, which is also
noted by Wilkins et al. (2018), who listed various organizations and their screening
recommendations.

20

Various options are available for screening. These options include both, stoolbased tests as well as structural exams. The stool-based exams are guaiac fecal occult
blood tests (gFOBT) or fecal immunochemical tests (FIT), which uses antibodies to test
for the presence of microscopic blood in the stool sample (Ahlquist, 2019). The benefits
to these tests are that they can be done at home and are relatively easy and quick to
perform. Ahlquist (2019) noted that screening with FIT every year not as helpful in the
detection of colorectal cancer as multitarget DNA stool-based tests or colonoscopies.
However, the author also interjected that FITs are more sensitive in detecting advanced
adenomas and cancer than gFOBTs (Ahlquist, 2019).
Structural exams, such as sigmoidoscopy and colonoscopy, are done by use of
flexible tubes equipped with a camera on the end, which allows direct visualization of
the inside of the colon wall; partially in a sigmoidoscopy, and completely during a
colonoscopy. Abdel-Rahman and Cheung (2019) advised that sigmoidoscopies should be
performed every 10 years, just like regular screening colonoscopies can be done every
10 years. During either procedure, polyps can be identified, removed, and tested.
In a study conducted by Hol et al. (2010), the authors found that flexible
sigmoidoscopy and colonoscopy were the preferred methods over stool-based
approaches for CRCS in patients who had previous screening, as well as those who had
never been screened before. Hoffman, Teubner, and Kiesslich (2014) called colonoscopy
the definite gold standard screening method for colorectal cancer. Ahlquist
acknowledged that the inside colon wall can be fully visualized and any polyps removed
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at the same time. It was also noted that the precision in adenoma detection during a
colonoscopy relies on the expertise and awareness of the proceduralist (Ahlquist, 2019).
Other screening tests are available. Among those are double-contrast barium
enemas, computed tomographic (CT) colonography or virtual colonoscopy, and capsule
colonoscopy, which are not as frequently used (Wilkins et al., 2018).
Screening Barriers
Not everyone eligible for colorectal cancer screening participates when they
reach the recommended age. Bromley, May, Federer, Spiegel, and Van Oijen (2015)
remarked that while African Americans constitute the ethnic group with the greatest
number of colorectal cancer diagnoses and death rates, they are also the group least
likely to present for an exam. The authors cited fear, lack of knowledge about the risks,
benefits, and screening procedure itself, lack of physician recommendation, and
financial difficulties among the top barriers for this subgroup to undergo colorectal
cancer screening. Barriers not only exist based on race or ethnicity but also because of
level of education, income, and insurance status (Redmond Knight, et al., 2015).
Attitudes and beliefs are barriers for more affluent and educated white adults, while
cost was the most predominant barrier in less educated, low-income black adults
(Redmond Knight et al., 2015).
Sahin, Aker, and Arslan (2017) noted fear of bad test results as the number one
barrier to receive colorectal cancer screening, followed by being embarrassed of the
test, and the screening potentially being painful and uncomfortable as the main reasons
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not to get screened. Cossu, Saba, Minerba, and Mascalchi (2018) pointed out that a lack
of knowledge concerning the screening process could lead to fear and anxiety about
what screening results would show and whether there would be discomfort or unease
during the procedure. Other barriers that were described included readiness, being too
busy, fear about the test, lack of conversation about screening with healthcare provider,
lack of insurance, insufficient time, no intentions to get screened, and a general distaste
towards screening (Ely, Levy, Daly, & Xu, 2016).
Similar findings come up in other articles. However, Katz, Young, Zimmermann,
Tatum, and Paskett (2018) noted that their results showed the test as not being a
priority or even an inconvenience as the most frequent answer, closely followed by the
belief that there is no family history of colorectal cancer, and therefore no need for
screening. Hasan et al. (2017) discovered that the majority of study participants would
have a colonoscopy screening if their doctor told them to and that they just don’t know
enough about colorectal cancer to make an informed decision.
Importance of Screening and Prevention
Early screening and prevention will reduce colorectal cancer related morbidity,
mortality, and healthcare cost. Using findings from current research and following the
best practices available can avert a cancer diagnosis for those with one or more risk
factors (Short et al., 2015). Apart from regular and timely screening and lifestyle
modifications, prevention measures include assessment of personal risk related to
genetics and heredity (Kolligs, 2016), consumption of fish and fish oil, a high intake of
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fiber, calcium, and vitamin D, and regular exercise (Marley & Nan, 2016). Of particular
interest was the fact that there can be a 20%-25% reduction in colorectal cancer risk
with physical activity (Santos Silva, et al., 2018). Conflicting information is found about
the daily use of aspirin as a preventive measure due to the danger of developing
bleeding in the gastrointestinal system (Gravitz, 2015). Since the risks outweigh the
benefits, aspirin is worth mentioning, but deserves caution.
Gender-specific Differences in Attitudes Toward Colorectal Cancer
McKinney and Palmer (2014) discussed how gender affects knowledge of and
worry about colorectal cancer, perceived risk of being diagnosed with the disease, and
CRCS intention. The findings suggested that there is no difference in how much men
worried about CRCS versus the level of worry in women and they also did not find a
difference in intention to receive CRCS. There was, however, a discrepancy in
knowledge, perceived risk, and understanding of colorectal cancer but this study was
only focused on African Americans in Florida. (McKinney & Palmer, 2014). In a study
conducted by White et al. (2018), it was observed that women had higher CRCS rates
than men although those results only included answers from participants aged 60-74.
Ritvo et al. (2013) learned that women were uncomfortable with the thought of how a
colonoscopy is performed, embarrassed about CRCS, and had a fear of colonic
perforation, while men displayed an avoidant attitude of procrastination, thought that
CRCS was unnecessary healthcare, and felt vulnerable. Other points mentioned were a
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better relationship between providers and women, more knowledge about colorectal
cancer in women, and greater emotional distance in regards to choosing CRCS in men.
Summary
Colorectal cancer, or cancer of the colon or rectum, is the third most common
and deadly cancer in the United States and ranks in the top five for leading cause of
cancer death around the world. Lifestyle choices, specifically modification of risk factors,
such as smoking, eating an unhealthy diet full of meat and fat and devoid of fruits,
vegetables, and dietary fiber, physical inactivity, and excessive alcohol consumption can
influence the risk for development of colorectal cancer. Treatment options depend on
staging. Colorectal cancer can be screened for by various methods, but the most
common are stool-based and direct visualization tests. Barriers to screening are
abundant. The most frequently named are fear of the test or what the results could be,
attitudes regarding perceived susceptibility, and cost. Timely and individualized
screening as well as a number of preventive measures can lead to early detection and
easier treatment as well as better health outcomes and decreased mortality. Limited
information is available about specifics regarding gender-related differences in attitudes
toward CRCS.
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Chapter 3
Methodology
Introduction
The purpose of this study was to assess the extent to which participants received
their primary CRCS by the recommended age and barriers that prevented timely CRCS.
Furthermore, this study was conducted to evaluate the difference in the specific barriers
to timely initial CRSC for men compared to women. This chapter describes the research
design, sample selection and technique, data collection procedures, instrumentation,
validity and reliability of the instrument, and data analysis.
Research Questions
This study addressed the following research questions:
1. What are the colorectal cancer screening practices among males and females
ages 45-55?
2. What potential barriers exist that prevent individuals from undergoing timely
colorectal cancer screening?
3. What are the knowledge levels of colorectal cancer screening among those who
have an have not received screening?
Research Design
A descriptive, cross-sectional, survey-based design was used for this study.
Descriptive data was used explain what happened in the sample by summarizing it using
measures of central tendency and dispersion (Thompson, 2009). A descriptive research
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design uses observation of a behavior or situation as it occurs naturally, without the
researcher’s interference or manipulation of variables (Kim, Sefcik, & Bradway, 2017). It
is helpful to use a descriptive design when an experiment is not practical, for instance
with limitations of time and budget to conduct the study, as was the case for the current
study. The cross-sectional study design was used because it assesses the variables at
one point in time and is largely used for population-based surveys (Setia, 2016). A crosssectional design is intended to provide estimates of the pervasiveness of a certain
illness, including attitudes and behaviors (Kesmodel, 2018). The time to conduct this
study was limited to three weeks and a cross-sectional design was therefore more
appropriate than a design that would require more time. Surveys make it possible to
sample a sizeable number of participants from a chosen population (Safdar, Abbo,
Knobloch, & Seo, 2016).
Sample Selection
This study was comprised of a convenience sample of men and women between
the ages of 45 and 55 years old, which is the newest recommended age at which to start
CRCS (American Cancer Society, 2020). Data collection took place during the spring
semester of 2020.
Convenience sampling was the sampling technique chosen for this study.
Convenience or opportunity sampling is the most customary when no other conditions
need to be met apart from the convenience of the person or persons conducting the
research (Farrokhi & Mahmoudi-Hamidabad, 2012). Using this type of sampling allows
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the researcher to utilize the part of a population that is close at hand and requires very
little resources (Hedt & Pagano, 2011). Convenience or opportunity sampling is used
most often because it saves time and money. The current study was limited in time to
only a small portion of the spring semester 2020 and there was a limited budget. A
geographical area from which participants are selected was not defined for this study
and no identification of geographical location was requested in the demographics.
Data Collection Procedures
The researcher contacted various individuals from organizations like Lifetime
Fitness Corporate, Minnesota Public Health Association, Sons of the American Legion,
and Minnesota Society for Public Health Education by email to inquire about them being
able and willing to distribute via email an introduction, purpose of the study, and the
survey link within their respective organizations. These individuals agreed and
distributed the online survey link along with the above-mentioned information to their
specific email lists with the request for the survey to be completed at the participants’
convenience. Additionally, postcards with the same information as noted above were
printed and left at the front desk of two locations of a local gastroenterology clinic.
Permission for this distribution was extended verbally as well as in writing to the
researcher. The cards were left at the two clinic sites with a request for them to be
distributed to those patients who met the inclusion criteria. Lastly, the link and
accompanying information were shared on social media by persons known to the
researcher as well as on city-specific social media sites, along with requests to also share
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the link to recruit further participants. The survey was conducted only by means of the
Qualtrics® web-based survey software and no paper copies were distributed.
Krejcie and Morgan (1970) developed a formula and a corresponding table for
determining research sample size needed to be representative of a given population.
According to that table, an estimated number of 384 participants were necessary to
ascertain the data needed for this survey to be representative of the study population
and to establish statistically meaningful and significant results. Having statistically
significant and meaningful results suggests that those results did not happen by chance.
Inclusion criteria for this study consisted of being male or female, 45 to 55 years
old, and having had or planning to have an initial colonoscopy for the purpose of
colorectal cancer screening. Exclusion criteria were being of an age that is outside of the
given age range and not answering any questions.
Instrumentation
Select items and questions from the National Cancer Institute’s Health
Information National Trends Survey 2003 (HINTS, 2003) were used to assess screening
practices, barriers to receiving CRCS, and knowledge about colorectal cancer (National
Cancer Institute, 2018). The HINTS 2003 survey instrument is available online in its
entirety and permission to use items was granted via personal email from the National
Institute of Health to the researcher. The items for the current study were used to
create a survey utilizing the Qualtrics® web-based software, which will collect survey
results.

29

The year 2003 was the first year during which the HINTS was conducted by the
National Cancer Institute (NCI) to research “the American public’s knowledge of,
attitudes toward, and use of cancer- and health-related information” (National Cancer
Institute, 2018, para. 1). The instrument is a survey originally designed to be delivered
via telephone and comprised of 14 separate sections to include household details,
health communication, cancer history and knowledge, specific cancers like colon,
breast, cervical, and prostate, and health-related behaviors like tobacco use, fruit and
vegetable intake, and exercise, overweight and obesity, general health status, and,
lastly, demographics. Each section has varying numbers of questions, ranging from 2 to
33. The types of questions in the HINTS 2003 vary. Some questions are multiple
choice/pick all that apply, some yes or no, and some are Likert-type.
As there are sections in the HINTS 2003 that were not applicable to this study,
particularly those related to other types of cancer and health-related behavior, only
those items associated with colorectal cancer were chosen to be included. Necessary
demographic items in the present study were limited to age, gender, race, and ethnicity.
Other demographic items were omitted. Items that were included from HINTS 2003
originated from the colon cancer section and included three Likert-type questions
related to perceived personal risk, 23 items related to screening knowledge and
behaviors in various formats and addressing colonoscopies as well as stool-based
screening tests, and two questions about detection and curability of colon cancer. Items
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CC-9, CC-11, CC-12 were omitted because they did not address any of the current study
variables.
Since the following questions were not addressed in the HINTS 2003 survey, they
were added to address research questions and variables to be measured. Apart from
question #1, they will be given a Likert-type response:
1. At what age did you have your first screening colonoscopy?
2. Did the colonoscopy prep bother you?
3. Were you fearful of the results?
4. Were you fearful of the test itself?
5. How easy was it to take off from work to have screening done?
All questions in the current study were numbered consecutively.
Descriptive information was gathered from the survey, which explored the
participants’ CRCS practices, the age at which screening first occurred, and any reasons
for the delay of screening. Moreover, the potential barriers to receiving timely CRCS
were established and the difference in these barriers between men and women were
uncovered.
Validity and Reliability
Minimal information was available regarding validity and reliability of this
national survey instrument, even though survey items were used in numerous articles
(National Cancer Institute, n.d.). Nelson et al. (2004) noted that “scientific validity
criteria emphasized including items that have been demonstrated to measure
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population-based constructs in reliable ways” (p. 447). The validity elements mentioned
by Nelson et al. (2004) included that self-reported information can provide valid
assessments for the adult population, and well-established measures of cancer-related
information or knowledge. Schnittker and Bacak (2014) remarked that the validity of a
self-reported health assessment such as HINTS 2003 is also greatly influenced by
knowledge levels of health-related issues and an increased use of technology to obtain
such knowledge. Ok, Marks, and Allegrante (2008) pointed out that the HINTS 2003
survey was created by “using constructs from established health communication and
behavior change models” (p. 640).
Reliability was only mentioned regarding the five communication item responses
in the study done by Ok, Marks, and Allegrante (2008), indicating that the results for all
of them were similar. Finney Rutten et al. (2019) reported that data quality was assured
by first conducting cognitive testing of new survey items in each HINTS instrument. This
was noted to grant valid measures of the constructs in question as well as minimal
inaccuracy in responses. Furthermore, Finney Rutten et al. (2019) related that, in
comparison with validated multi-item scales, “single-item measures can have similar
test–retest reliability and construct validity” (p. 8).
Data Analysis
Data analysis was conducted using the IBM Statistical Package for Social Sciences
(IBM SPSS® Statistics 26). Descriptive statistics, including frequencies, percentages, and
means, were calculated to describe data, a Mann-Whitney test was performed and an
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alpha level of .05 selected to assess differences in CRCS between males and females
(Table 1).
Table 1
Table of Specifications
Research Question
(RQ)

Survey items or
scales used to
assess RQ’S

Level of data
(Nominal, Ordinal,
Interval/Ratio)*

Analysis needed
to assess RQ

1
2
3
4
5
6

Nominal and Ordinal

Descriptive
statistics
including
frequencies,
percentages,
and measures of
central tendency

1. What are the
colorectal cancer
screening practices
among males and
females ages 45-55?

Mann-Whitney
Test
2. What potential
barriers exist that
prevent individuals
from undergoing
timely colorectal
cancer screening?

7

Nominal and Ordinal

Descriptive
Statistics
including
frequencies,
percentages,
and measures of
central tendency

3. What are the
knowledge levels of
colorectal cancer
screening among
those who have an
have not received
screening?

8
9
10
11
12
13

Nominal and Ordinal

Descriptive
statistics
including
frequencies,
percentages,
and measures of
central tendency

Note. *Indicates level of data for survey items, not RQ’s
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Summary
Data will be collected from items from the National Cancer Institute’s HINTS
2003 survey instrument in addition to several added questions, addressing the study
variables and research questions. Sampling will be conducted using cluster and snowball
sampling and data will be collected via mixed methods. Data analysis will be performed
using IBM SPSS® and descriptive statistics as well as independent samples t-test used to
analyze and describe study findings.
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Chapter IV
Results
Introduction
The purpose of this study was to assess the extent to which participants received
their primary colorectal cancer screening by the recommended age and any barriers
that prevented participants from receiving timely colorectal cancer screening.
Furthermore, the researcher sought to evaluate differences in barriers to timely initial
colorectal cancer screening for men compared to women. This chapter gives an
overview of the results of the study.
A total of 316 surveys were collected via Qualtrics® web-based survey software
from potential participants and 161 surveys (51%) were used for data analysis. The
remainder of the surveys (49%, n = 155) were rejected due to incomplete/missing data
(more than 5%) or the participants’ age outside of the required range of 45-55 years.
Demographics of the Sample
The sample consisted of 161 adults between the age of 45-55 years of age.
Participants were primarily female (82%), non-Hispanic (96.9%), and Caucasian/White
(94.4%). The mean age of participants was 50.07 years (SD = 3.153) (Table 2).
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Table 2
Participant Demographics
Item

n(%)

Sex*

Item

n(%)

Age
Male 28(17.4)
Female 132(82)

Race*
Caucasian/White 152(94.4)
African American/Black
1(0.6)
Asian
2(1.2)
Other
2(1.2)
Two or more races
3(1.9)
Ethnicity*
Hispanic
3(1.9)
Non-Hispanic 156(96.9)

45 Years 12(7.5)
46 Years 11(6.8)
47 Years 15(9.3)
48 Years 24(14.9)
49 Years 13(8.1)
50 Years 18(11.2)
51 Years 12(7.5)
52 Years 11(6.8)
53 Years 12(7.5)
54 Years 13(8.1)
55 Years 20(12.4)

Note. *Totals not equaling 100% indicates missing data.
Assessment of Research Questions
What are the colorectal cancer screening practices among males and females
ages 45-55?
Out of the sample of 161 participants, 151 (93.8%) have never had a
sigmoidoscopy, 73 (45.3%) have never had a colonoscopy, 71 (44.1%) have not had
either, and 144 (89.4%) have never done a home stool blood test. Seventeen
participants (10.6%) have used a home stool blood test kit. Among those who have used
a home stool blood test kit, seven (4.3%) used a home stool blood test kit less than a
year ago, four (2.5%) used a home stool blood test kit more than a year but no more
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than two years ago, one (0.6%) used a home stool blood test kit more than two years
but not more than five years ago, and five (3.1%) used a home blood test kit more than
five years ago. For reasons that were not specified in the study, 33 (20.5%) participants
had their first screening colonoscopy before the age of 45. A total of 22 (13.7%)
participants were screened between 45 and 49 years of age, 26 (16.1%) had their first
screening when they were 50 or 51 years old, seven (4.3%) at age 52 or 53, and one
participant (0.6%) could not remember when she had her first screening. Ninety
participants (55.9%) have received CRCS via sigmoidoscopy or colonoscopy. Among
those participants, 32 (19.9%) Received CRCS within the past year, 44 (27.3%) more than
a year but not more than five years ago, 10 (6.2%) more than five but less than 10 years
ago, and four (2.5%) had their last screening more than 10 years ago. Fifty-two
participants (32.3%) have only had one CRCS, while 37 participants (23%) have had more
than one. Out of those 37 participants, five (3.1%) reported having had CRCS within the
past year, 17 (10.6%) between one and five years, 11 (6.8%) between five and 10 years,
and four (2.5%) more than 10 years between CRCS (Table 3).
Table 3
Participants’ Screening Practices

Item
1. Have you ever had a sigmoidoscopy?
Yes
No

n(%)

10(6.2)
151(93.8)

37

Table 3 continued

Item
2. Have you ever had a colonoscopy?
Yes
No
3. Age at first CRCS
Not yet
Before 45
45-49
50-51
52-53
Can’t remember
4. Most recent stool blood test
Never
A year ago or less
Between 1 and 2 years ago
Between 2 and 5 years ago
More than 5 years ago
5. Most recent sigmoidoscopy/colonoscopy
A year ago or less
More than 1 but no more than 5 years ago
More than 5 but no more than 10 years ago
Over 10 years
I have never had either
6. how many years since previous CRCS?*
A year ago or less
More than 1 but no more than 5 years ago
More than 5 but no more than 10 years ago
Over 10 years
I have only had one CRCS
I have never had a sigmoidoscopy/colonoscopy

n(%)

88(54.7)
73(45.3)
72(44.7)
33(20.5)
22(13.7)
26(16.1)
7(4.3)
1(0.6)
144(89.4)
7(4.5)
4(2.6)
1(0.6)
5(3.1)
32(19.9)
44(27.3)
10(6.2)
4(2.5)
71(44.1)
5(3.1)
17(10.6)
11(6.8)
4(2.5)
52(32.3)
71(44.1)

Note. *Totals not equaling n = 161(100%) indicates missing data
ͣSurvey items/Questions were adapted from National Cancer Institute (2003)
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What potential barriers exist that prevent individuals from undergoing timely
colorectal cancer screening?
Not every participant answered items in this portion of the survey, which left
anywhere from 26.1% to 71.4% of missing data (Table 4). Of those that did answer, 12
participants (7.5%) said that ‘didn’t know I needed this test’ was a major barrier and 10
(6.2%) called it a moderate barrier. CRCS being too expensive or the participant not
having insurance was a major barrier to 11 (6.8%) and a moderate barrier to nine (5.6%)
participants. Close to a quarter of participants (n = 38, 23.6%) also said that they put it
off or didn’t get around to it, with 11 (6.8%), 14 (8.7%), and 13 (8.1%) choosing this
respectively for major, moderate, or minimal barrier.
The greatest reported major barrier to receiving CRCS among the participants
was that the they did not have a doctor’s order or they were not told by their doctor
that they needed it (n = 23, 14.3%), while 12 participants (7.5%) called it a moderate
barrier. This is equally followed by the test being too painful, unpleasant, or
embarrassing as a major (n = 17, 10.6%) or moderate (n = 19, 11.8%) barrier and not
having had any problems or symptoms as a major (n = 17, 10.6%) or moderate (n = 10,
6.2%) barrier. Within the eligible age range, 15 participants (9.3%) ranked their age or
thought that they were too young as a major and 10 (6.2%) as a moderate barrier.
One notable finding was that a total of 63 participants (54.8%) reported the prep
for CRCS presented some type of barrier with 15 (9.3%)saying it was a major, 27 (16.8%)
saying it was moderate, and 21 (13%) saying it was a minimal barrier. Fifty-six
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participants (47.9%), found the test too painful, unpleasant, or embarrassing, rating it a
major (n = 17, 10.6%), moderate (n = 19, 11.8%), barrier (Table 4). Lastly, fear also
generated obstacles for CRCS. Ten participants each (6.2%) conveyed major fear of the
test as well as the results while 13 participants (8.1%) were moderately fearful of the
test versus eight (5%) who were moderately fearful of the result. Specific comments in
this section included that arranging a driver meant that another person had to take off
work, the negative side of undergoing the prep, and a general dislike for doctors.
Table 4
Potential Barriers for CRCS
Major
Barrier
n(%)

Moderate
Barrier
n(%)

Minimal
Barrier
n(%)

No
Barrier at
All
n(%)

Total*

1. No reason

3(1.9)

2(1.2)

9(5.6)

105(65.2) 119(73.9)

2. Didn’t need it

9(5.6)

6(3.7)

11(6.8)

91(56.5)

117(72.7)

3. Didn’t know I needed
this test
4. Doctor didn’t order
it/didn’t say I needed it
5. Haven’t had any
problems/no symptoms
6. Put it off/didn’t get
around to it
7. Too expensive/no
insurance
8. Too painful, unpleasant,
or embarrassing
9. Had another type of
colon exam

12(7.5)

10(6.2)

8(5)

87(54)

117(72.7)

23(14.3)

12(7.5)

12(7.5)

71(44.1)

118(73.3)

17(10.6)

10(6.2)

16(9.9)

72(44.7)

115(71.4)

11(6.8)

14(8.7)

13(8.1)

79(49.1)

117(72.7)

11(6.8)

9(5.6)

15(9.3)

83(51.6)

118(73.3)

17(10.6)

19(11.8)

20(12.4)

61(37.9)

117(72.7)

1(0.6)

2(1.2)

4(2.5)

n(%)

106(65.8) 113(70.2)
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Table 4 continued
Major
Barrier
n(%)

Moderate
Barrier
n(%)

Minimal
Barrier
n(%)

No
Barrier at
All
n(%)

Total*

10. Don’t have doctor

3(1.9)

4(2.5)

7(4.3)

99(61.5)

113(70.2)

11. Never heard of
it/never thought about
it
12. Age/thought they were
too young
13. Preparing for the
colonoscopy bothers
me
14. I am fearful of the test

3(1.9)

3(1.9)

8(5)

95(59)

109(67.7)

15(9.3)

10(6.2)

13(8.1)

76(47.2)

114(70.8)

15(9.3)

27(16.8)

21(13)

52(32.3)

115(71.4)

10(6.2)

13(8.1)

20(12.4)

71(44.1)

114(70.8)

10(6.2)

8(5)

17(10.6)

78(48.4)

113(70.2)

3(1.9)

6(3.7)

13(8.1)

92(57.1)

114(70.8)

3(1.9)

1(0.6)

0(0)

42(26.1)

46(26.6)

15. I am fearful of the
results
16. Could not get time off
from work
17. Other

n(%)

Note. *Totals not equaling n = 161(100%) indicates missing data
ͣSurvey items/Questions were adapted from National Cancer Institute (2003)
The results of the Mann-Whitney tests showed that males considered the
following attitudes as a lesser barrier than women or women saw greater obstacles in
the following: ‘no specific reason’ (U = 1013.5, z = -2.181, p = .029); ‘didn’t need it’ (U =
834, z = -3.097, p = 0.002); ‘didn’t know I needed this test’ (U = 888, z = -2.459, p =
0.014); ‘too expensive/no insurance’ (U = 921, z = -2.147, p = 0.032); ‘had another type
of colon exam’ (U = 985, z = -2.185, p = 0.029); ‘never heard of it/never thought about it’
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(U = 816, z = -2.078, p = 0.038) ‘I am fearful of the results’ (U = 816, z = -2.566, p = 0.010)
(Table 5).
Table 5
Mann-Whitney Test Results
Barrier

Sex

n

Mean
Rank

MannWhitney
U

Z

pvalue

No specific reason

Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female

26
92
26
90
26
90
25
92
26
88
26
90
26
91
25
91
26
86
26
86
23
85
26
87
26
88
26
87

52.48
61.48
45.58
62.23
47.65
61.63
49.38
61.61
53.88
58.57
55.27
59.43
48.92
61.88
67.12
56.13
51.38
58.05
52.33
57.76
47.48
56.40
51.48
58.65
57.56
57.48
55.00
57.60

1013.50

-2.181

p<.05

834.00

-3.097

p<.05

888.00

-2.459

p<.05

909.50

-1.825

p>.05

1050.00

-.737

p>.05

1086.00

-.674

p>.05

921.00

-2.147

p<.05

922.00

-1.576

p>.05

985.00

-2.185

p<.05

1009.50

-1.345

p>.05

816.00

-2.078

p<.05

987.5

-1.177

p>.05

1142.50

-.011

p>.05

1079.00

-.441

p>.05

Didn't need it
Didn't know I needed this
test
Doctor didn’t order it/didn’t
say I needed it
Haven’t had any
problems/no symptoms
Put it off/didn’t get around
to it
Too expensive/no insurance
Too painful, unpleasant, or
embarrassing
Had another type of colon
exam
Don’t have doctor
Never heard of it/never
thought about it
Age/thought they were too
young
Preparing for the
colonoscopy bothers me
I am fearful of the test
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Table 5 continued
Barrier

Sex

n

Mean
Rank

MannWhitney
U

Z

pvalue

I am fearful of the results

Male
Female
Male
Female
Male
Female

26
86
26
87
9
37

44.88
60.01
52.81
58.25
25.50
23.01

816.00

-2.566

p<.05

1022.00

-1.098

p>.05

Could not get time off from
work
Other

Note. *Totals not equaling n = 161 indicates missing data.
ͣSurvey items/Questions were adapted from National Cancer Institute (2003)
What are the knowledge levels of colorectal cancer screening among those
who have and have not received screening?
The results revealed a mean knowledge score of 2.37 (SD = 1.12) with possible
scores ranging from 0-6. When asked what participants knew about colorectal cancer
screening, roughly half (n = 80, 49.7%) were able to correctly identify the tests used for
detection of colorectal cancer. Ninety-two participants (57.1%) knew at what age people
are supposed to perform home stool blood tests, but only 54 participants (33.5%) knew
the frequency at which the stool blood test should be performed. Just over 75% (n =
122) of participants identified the age at which people are supposed to have
sigmoidoscopy or colonoscopy exams correctly. Yet, only 10 participants (6.2%) knew at
which frequency these exams generally should be performed (Table 6).
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Table 6
Colorectal Cancer Screening Knowledge Levels

Item

Which of the following tests can detect colorectal cancer?
At what age are people supposed to start doing home stool
blood tests?
In general, once people start doing home stool blood tests,
about how often should they do them?
At what age are people supposed to start having
sigmoidoscopy or colonoscopy exams?
In general, once people start having sigmoidoscopy exams,
about how often should they have them?
In general, once people start having colonoscopy exams,
about how often should they have them?

Correct
n(%)

Incorrect
n(%)

80(49.7)
92(57.1)

81(50.3)
69(42.9)

54(33.5) 107(66.5)
122(75.8)

39(24.2)

24(14.9) 137(85.1)
10(6.2) 151(93.8)

ͣSurvey items/Questions were adapted from National Cancer Institute (2003)
Summary
A total of 161 usable surveys were utilized for analysis. The sample was made up
of mostly non-Hispanic Caucasian/white females, evenly distributed across the age
range in question. The greater part of participants has never had a sigmoidoscopy or
performed a home stool blood test and just over half of them reported having had a
colonoscopy. A significant number of participants started CRCS before the generally
recommended age of 50. More than half of the participants reported not having any
other barriers to CRCS than those listed in the survey. Lack of an order from a healthcare
provider or being told that CRCS was needed was cited as the greatest barrier to
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receiving CRCS among the participants while not having a doctor and having had
another colon exam was cited as the least. Close to half of the participants established
that the prep was a barrier and too painful, unpleasant, or embarrassing. Overall, the
results showed that all the mentioned barriers were greater for women than they were
for men. Approximately half of participants were knowledgeable about which test
would identify colorectal cancer, slightly more were aware of the age at which home
stool blood testing starts, and about three quarters of participants knew when to start
endoscopic CRCS. Knowledge of frequency of either stool-based tests or CRCS via
sigmoidoscopy/colonoscopy was minimal.
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Chapter V
Interpretation of Findings
Introduction
The purpose of this study was to assess the extent to which participants received
their primary colorectal cancer screening by the generally recommended age and any
barriers that prevented participants from receiving timely colorectal cancer screening.
Moreover, the researcher sought to evaluate the difference in barriers for timely initial
colorectal cancer screening for men compared to women.
This research focused on establishing CRCS practices of individuals aged 45-55
years old, their potential barriers towards CRCS, and participants’ knowledge levels
surrounding CRCS. An interpretation and explanation of the research questions and
findings, discussion, and recommendations are included in this chapter.
Overview
The findings indicate that non-Hispanic, Caucasian/White, and female
participants were the most prevalent respondents to participate in the survey. Since the
general population of the United States is not just made up of non-Hispanic,
Caucasian/White, females but rather a much more diverse group of people, the results
of this survey are skewed towards only a small portion of the general population and do
not give an adequate representation of the population as a whole. Ages of participants
ranged from 20 to 78 years. However, those outside of the desired age range were
eliminated from the sample.
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Sigmoidoscopy and home stool blood tests were the two screening modalities
with which the participants had the least experience. Additionally, nearly half of
participants have not had any CRCS at all. There was no option to specify possible
reasons why a participant may have had CRCS before the age of 45. However, out of
those participants who have had a colonoscopy, over a third of participants reported
that they started screening before the generally recommended age of 50, which
correlates with over two-thirds of participants having had more than one colonoscopy
already. The number of those that have waited more than ten years in between
colonoscopy screenings was small.
In regards to barriers, colon exams other than those focused on in the present
study, like barium enemas, lower GI series, CT colonography, or capsule colonoscopy
were not mentioned as much of a barrier by most participants either, because these
tests are not commonly done for CRCS. Not having a doctor was only reported as a slight
obstacle to receiving CRCS. Conversely, not having a doctor’s order or their doctor not
mentioning the need for CRCS, the test being too painful, unpleasant, or embarrassing;
and not having any problems or symptoms of colon cancer were named as the leading
obstacles.
More than half of the participants reported that the test prep presented some
sort of barrier and comments were made that ‘the prep is awful,’ ‘the prep is horrible,’
and ‘I have seen what prep does to people when I often pick them up in the early
morning hours for severe dehydration, weakness and altered mental status.’ Other
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comments suggested having to find a responsible person/driver means that another
person must take time off work, presenting an imposition to more than just the patient,
and a general dislike for doctors also could pose as a barrier.
When conducting comparisons between the barriers of males versus females, all
statistically significant comparisons showed a greater barrier for females than for males.
Those items include ‘no specific reason,’ ‘didn’t need it,’ ‘didn’t know I needed this test,’
‘too expensive/no insurance,’ ‘had another type of colon exam,’ ‘never heard of it/never
thought about it,’ and ‘I am fearful of the results.’
Knowledge levels were varied. Almost half of the participants were able to
correctly identify the tests used for detection of colorectal cancer. Over half correctly
identified the general age at which CRCS via home stool blood tests is supposed to start,
but only a third knew at what frequency they should be performed. Similar results were
seen with the identification of starting age and frequency for
sigmoidoscopy/colonoscopy. Three quarters of participants knew the general
recommended age but less than 10% of participants correctly named the frequency.
Discussion
This study revealed some important findings. Colonoscopies were the most
frequently reported CRCS test in this sample. Sovich, Sartor, and Misra (2015) pointed
out that “colonoscopy is the gold standard for CRC screening and the most common
method in the United States” (p. 1) and that approximately two-thirds of adults over 50
in the United States follow CRCS recommendations from the United States Preventive
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Services Task Force. The average age of participants was just over 50 years old (M =
50.07, SD = 3.153) with 93 (57.8%) of them 50 years of age and under and more than
half of them (n = 83, 53.9%) reported having had at least one colonoscopy. Considering
that the general recommendation is to do CRCS from 50-75 years of age, which is likely
the age range Sovich, Sartor, and Misra (2015) used to report their findings since there
was no age limitation noted in the article, it is encouraging to see that the present
sample is ahead of the curve.
Salimzadeh, Delavari, Montazeri, and Mirzazadeh (2012) found that “four
commonly cited reasons for not having CRC tests were “doctor did not recommend the
test,” “did not think it was needed,” “never think of the test,” and “no
symptoms/problems” which were reported by 29%, 26%, 20%, and 17% of the
participants, respectively” (p. 29). Hughes, Watanabe-Galloway, Schell, and Soliman,
(2015) identified the cost of CRCS and lack of insurance, feelings of embarrassment, lack
of knowledge of benefits of CRCS, and access to care as barriers to receiving CRCS.
Within the sample of this study, the most prevalent barriers to receiving CRCS were
found to be no physician order or discussion that the test is needed, a lack of signs or
symptoms of colorectal cancer, and the test itself creating emotional and physical
discomfort. Many participants also designated the prep as appalling. Therefore, the
outcomes of this study are consistent with previous findings.
Another similarity this study revealed to the existing literature was that there is a
general knowledge deficit of the screening process, which leads to anxiety over mental
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and physical discomfort during the exam as well as potentially detrimental test results.
Hasan et al. (2017) reported that a general knowledge deficit about colorectal cancer
prevented patients from making an informed decision whether to receive CRCS.
Salimzadeh et al. (2016) also determined that there was a strong knowledge deficit in
regards to both, colorectal cancer, and CRCS practices.
Overall, the current study showed that the perception of barriers was higher in
women than in men. Wong et al. (2013) described the same phenomenon. Their
findings stated that more women chose all of the following categories as a greater
barrier than men did: preference of not knowing about a positive cancer diagnosis, fear
of finding out that they have colorectal cancer, cost of the screening, potentially
dangerous side effects of colonoscopies, painful tests, embarrassment of having a
colonoscopy performed, and inconvenience of CRCS. These results match what the
current study found when making the contrast between barriers for men compared to
those for women.
A larger sample that is more representative of the general population in this
country may have resulted in different outcomes, but it is encouraging to see that this
sample shows screening numbers that are in line with the recommendations, especially
considering that the age group chosen for this study encompasses only the lower end of
the recommended screening ages. Prevention happens when people get timely
screening. Therefore, the facts that such a large portion of the sample have already had
multiple screenings, evidenced by reporting time between previous and most recent
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screening, and that one participant even specified getting screened every time the
doctor recommended it, are reassuring that barriers are not keeping patients from
following CRCS recommendation.
Recommendations for Healthcare Providers
A large portion of the participants viewed the lack of doctor’s order or
encouragement for a colonoscopy from their primary care provider as a major barrier to
receiving CRCS. Healthcare providers therefore need to add CRCS to the list of regular
screening procedures, like mammograms or blood tests for prostate cancer. Education
can be done during annual wellness visits or check-ups with the provider. The American
College of Gastroenterology (ACG, n.d.) offers a colorectal cancer community education
toolkit which includes online links where patients can explore information by
themselves, slides containing pertinent information in easy-to-understand language,
brochures to hand out and posters to hang on the clinic office walls, as well as podcasts
and videos. These resources are ready and easy to use. Since women seem to be more
hesitant in receiving CRCS, gender-specific education, which is available from the ACG, is
appropriate to use when talking to one sex over the other.
However, more detailed information about the medical and clinical aspects of
colorectal cancer and CRCS can always be gathered from sites like the CDC, ACS, and
major healthcare facilities. It is highly important that members of the healthcare team
impress upon their patients the seriousness of timely screening, regardless of presence
or absence of signs and symptoms, and potential consequences that may result if timely
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screening does not happen. In a study done by Gupta, Brenner, Ratanawongsa, and
Inadomi (2014), it was noted by the authors that a trusting relationship with a patient’s
primary care provider can increase adherence to CRCS recommendations. The general
definition of trust is the belief that the provider is truthful, caring, compassionate, and
has the best interest of the patient at heart (Chandra, Mohammadnezhad, & Ward,
2018). It is, therefore, critical that primary healthcare providers establish a trusting
relationship with their patients if they want to see improved adherence with screening
suggestions. According to Chandra, Mohammadnezhad, and Ward (2018), that trusting
relationship can be established through effective communication, the way the provider
treats the patient, and how well the provider demonstrates knowledge of the patient.
Another opportunity would be electronic health maintenance reminders sent
directly to both, the primary care providers and the patients who meet eligibility
criteria, like age, time since previous CRCS, family history, personal history, or risk
factors. Such information would need to be added to the electronic medical/health
records by someone on the healthcare team and flagged for upcoming visits. The Office
of the National Coordinator for Health Information Technology (ONC, 2019) noted that
public health outcomes are enhanced with improved quality of care screenings for
several chronic diseases through clinical alerts and reminders in the electronic health
record (EHR). Other health maintenance reminders like vaccine boosters and
mammograms or pap smears already appear in EHRs, so adding CRCS should not be
difficult.
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Public service announcements via television commercials, radio
announcements, or advertisements on social media and in printed magazines are other
means to increase awareness of colorectal cancer. There are plenty of public service
announcements regarding breast cancer with the Susan B. Komen Foundation and their
‘dress pink for breast cancer’ campaign as well as the designation of October being
breast cancer awareness month and also tobacco cessation campaigns like ClearWay
Minnesota’s QUITPLAN (2020) or the National Institute of Health’s smokefree.gov (n.d.),
which includes free resources, tools, and tips for smokers who want to quit. Much less
awareness is surrounded by the fact that March is colorectal cancer awareness month
and the official color of the awareness ribbon is royal blue but not for the lack of
availability of educational material. Public health agencies have a great opportunity to
change the numbers of new colorectal cancer diagnoses and decrease deaths if they
promote a campaign that appeals to all adults and helps mitigate fear of the test and
similarly abate fear of the results. The ACG provides social media ready resources, some
even separated to address men and women individually, that are easily accessible and
can be used to promote CRCS. Having a way to focus on either sex separately makes it
easier to alleviate concerns that are more insistent in women, as this study showed that
women have greater barriers than men do.
Unfortunately, the colon is a taboo subject for many people. Rendering CRCS a
less stigmatized procedure by increasing awareness with bright and colorful ad
campaigns can also decrease embarrassment, make it more acceptable, and increase
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adherence. The ACG has ample resources available to accomplish that task.
Furthermore, health insurance providers need to revise policies and procedures that
make it easier for patients to receive CRCS so that financial constraints don’t end up
having even more costly consequences. The ACS (2018) advocates for all patients to
have access to screening established by evidence-based guidelines and regardless of
insurance coverage. The current study points to not having insurance and the test being
too expensive as a barrier for 35 participants, which is more than 20%, making this a
significant hinderance. Unfortunately, every health insurance can determine what their
own plans include and how much, if anything, the patients must pay in addition to what
insurance covers. That makes it difficult to recommend specific changes since there is no
uniformity, unless those changes are advocated for and effected in the political arena.
Contacting local members of congress is a great option to start with.
One more way to help with CRCS behavior change would be to add health and
wellness coaches or care coordinators as regular and permanent members of the
healthcare team. Langley (2019) notes that health coaches effect behavior changes by
inspiring motivation and helping people build up self-care skills. Coaches collaborate
with patients on patient-identified health goals, improvement of general well-being, and
facilitation of lifestyle changes in a growing reliance and partnership with providers
(Langley, 2019). Thom et al. (2016) related the benefits of health coaches as part of the
healthcare team and stressed areas like development of a trusting relationship, personal
and decision-making support, coaches being a bridge between patients and their
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providers, and coach availability. Coaches could take over patient support of selfmanagement in areas such as health maintenance, medication compliance,
recommended preventative measures like vaccines and screenings, and making changes
in physical activity and stress reduction, effectively empowering the patients to take
ownership in their own health and well-being. Gastala et al. (2018) remarked that
“health coaches are behavior change specialists who partner with patients to identify
goals and barriers, reinforce recommendations, and coordinate care” (p. 526). Adding
health coaches to any health care team is, therefore a valuable asset and can help
patients stay current on preventive screenings, like CRCS.
Lastly, many see the prep and physical clearing of the colon as a barrier to
getting screened. Unfortunately, having a clean colon is a prerequisite to CRCS and will
remain necessary. Side effects can happen while doing a bowel prep because the body
loses a lot of fluids and this can be uncomfortable and lead to dehydration, nausea,
vomiting, and weakness. If that happens, proceduralists can add such information to the
medical record triggering recommendations to add electrolytes and extra fluids on the
fasting day to help alleviate side effects during subsequent preps and therefore making
the bowel prep more tolerable.
Recommendations for Future Research
The survey was only open for three weeks on social media and distributed via
postcard at two locations of a local gastroenterology clinic for two weeks, which did not
yield the desired number of participants. To get a more appropriate representation of
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the population with much higher numbers of participants, this survey needs to be
distributed in a larger geographical area and be available for a longer time. This study
also only focused on patients in a limited age group. However, in light of increasing
numbers of colorectal cancer diagnoses in patients younger than 50, and the majority of
cases on patients older than the participants, it might yield further important
information to extend a survey such as this to other age groups.
Males as well as ethnic and racial groups were underrepresented in this study.
By expanding the geographic distribution of the survey, the racial distribution of
participants could potentially be more consistent with that of the general American
public. This survey was conducted on social media, and in middle-class suburban clinics,
which likely did not get the same demographics and survey results we would see in
more underprivileged areas of the country, making that another opportunity to look
further into CRCS practices and barriers. In this regard, it might also be helpful to inquire
about education level, income, and access to preventive care in general.
When assessing CRCS practices, it may be helpful to address reasons why
participants have had their first colonoscopy before the recommended starting age of
45 or 50, which this study did not address. It would also be helpful to conduct pilot
testing as one comment was made that the items that assessed attitudes did not make
sense. Feedback about how the survey items are written understood can provide a
valuable resource to assure higher participation by even those that are not very
healthcare literate. Adding other CRCS methods that are much less prevalent will also
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provide added awareness of screening practices that may not adhere to the norm and a
distribution across demographics.
Summary
While more women responded to the survey, men reported fewer perceived
barriers. Future research needs to expand not only the time frame of the study and the
geographical area to get a more diverse demographic but also include impact of socioeconomic status and underlying comorbidities as barriers to timely CRCS.
This study did not yield the expected number of participants and the sample was
not very diverse, yet there were some important findings that can have an impact on
future healthcare practices as well as future research. Healthcare providers or other
healthcare team members need to increase time spent on patient education and followthrough. Colorectal cancer should not be treated any differently than prostate or breast
cancer and more public health campaigns to that effect are needed to make sure
everyone knows that CRCS equals prevention.
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